Thermo Fisher Scientific Inc. announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry.

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

A new mum told how she got a devastating diagnosis just after giving birth to her son. Georgina Colman, 48, sought medical ...

New mum Georgina Colman suddenly began to suffer from headaches and double vision shortly after giving birth to her son but ...

"Slow Ride" singer Colt Ford described how he switched to a healthier lifestyle after he "died twice" from a near-fatal heart ...

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...